Regulation of osteoclast differentiation (Q28593319)

31 January 2017

1 reference

Europe PubMed Central

title

Regulation of osteoclast differentiation (English)

1 reference

A disintegrin and metallopeptidase domain 8

31 January 2017

main subject

1 reference

GOA release 2020-03-11

author name string

G. David Roodman

series ordinal

1

1 reference

31 January 2017

language of work or name

English

0 references

publication date

1 April 2006

1 reference

Annals of the New York Academy of Sciences

31 January 2017

published in

1 reference

31 January 2017

volume

1068

1 reference

31 January 2017

page(s)

100–109

1 reference

Src kinase activity is essential for osteoclast function

31 January 2017

cites work

1 reference

https://api.crossref.org/works/10.1196/ANNALS.1346.013

RANK is essential for osteoclast and lymph node development

21 April 2017

1 reference

https://api.crossref.org/works/10.1196/ANNALS.1346.013

ADAM8: a novel osteoclast stimulating factor

21 April 2017

1 reference

https://api.crossref.org/works/10.1196/ANNALS.1346.013

Bifurcation of osteoclasts and dendritic cells from common progenitors

21 April 2017

1 reference

https://api.crossref.org/works/10.1196%2FANNALS.1346.013

M-CSF, TNFα and RANK ligand promote osteoclast survival by signaling through mTOR/S6 kinase

21 January 2018

1 reference

https://api.crossref.org/works/10.1196%2FANNALS.1346.013

21 January 2018

1 reference

https://api.crossref.org/works/10.1196%2FANNALS.1346.013

Mechanisms involved in bone resorption

21 January 2018

1 reference

https://api.crossref.org/works/10.1196%2FANNALS.1346.013

A RANK/TRAF6-dependent signal transduction pathway is essential for osteoclast cytoskeletal organization and resorptive function

21 January 2018

1 reference

https://api.crossref.org/works/10.1196%2FANNALS.1346.013

B lymphocytes inhibit human osteoclastogenesis by secretion of TGFbeta

21 January 2018

1 reference

https://api.crossref.org/works/10.1196%2FANNALS.1346.013

Preclinical studies with zoledronic acid and other bisphosphonates: impact on the bone microenvironment

21 January 2018

1 reference

https://api.crossref.org/works/10.1196%2FANNALS.1346.013

Osteopetrosis in mice lacking haematopoietic transcription factor PU.1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1196%2FANNALS.1346.013

Inhibition of RANKL-induced osteoclastogenesis by (-)-DHMEQ, a novel NF-kappaB inhibitor, through downregulation of NFATc1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1196%2FANNALS.1346.013

Parathyroid hormone stimulates TRANCE and inhibits osteoprotegerin messenger ribonucleic acid expression in murine bone marrow cultures: correlation with osteoclast-like cell formation

21 January 2018

1 reference

https://api.crossref.org/works/10.1196%2FANNALS.1346.013

p38 MAPK-mediated signals are required for inducing osteoclast differentiation but not for osteoclast function

21 January 2018

1 reference

https://api.crossref.org/works/10.1196%2FANNALS.1346.013

NF-kappaB p50 and p52 expression is not required for RANK-expressing osteoclast progenitor formation but is essential for RANK- and cytokine-mediated osteoclastogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1196%2FANNALS.1346.013

Regulation of receptor activator of nuclear factor-kappa B ligand and osteoprotegerin mRNA expression by parathyroid hormone is predominantly mediated by the protein kinase a pathway in murine bone marrow cultures

21 January 2018

1 reference

https://api.crossref.org/works/10.1196%2FANNALS.1346.013

Soluble receptor activator of nuclear factor kappaB ligand-osteoprotegerin ratio predicts survival in multiple myeloma: proposal for a novel prognostic index

21 January 2018

1 reference

https://api.crossref.org/works/10.1196%2FANNALS.1346.013

Macrophage inflammatory protein-1alpha is an osteoclastogenic factor in myeloma that is independent of receptor activator of nuclear factor kappaB ligand

21 January 2018

1 reference

https://api.crossref.org/works/10.1196%2FANNALS.1346.013

Interleukin-1beta and tumor necrosis factor-alpha, but not interleukin-6, stimulate osteoprotegerin ligand gene expression in human osteoblastic cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1196%2FANNALS.1346.013

CytokineRegulation and the signaling mechanism of osteoclast inhibitory peptide-1 (OIP-1/hSca) to inhibit osteoclast formation

21 January 2018

1 reference

https://api.crossref.org/works/10.1196%2FANNALS.1346.013

Osteoclast inhibitory peptide 2 inhibits osteoclast formation via its C-terminal fragment

21 January 2018

1 reference

https://api.crossref.org/works/10.1196%2FANNALS.1346.013

Identification of human asparaginyl endopeptidase (legumain) as an inhibitor of osteoclast formation and bone resorption

21 January 2018

1 reference

https://api.crossref.org/works/10.1196%2FANNALS.1346.013

Eosinophil chemotactic factor-L (ECF-L): a novel osteoclast stimulating factor

21 January 2018

1 reference

https://api.crossref.org/works/10.1196%2FANNALS.1346.013

Fosl1 is a transcriptional target of c-Fos during osteoclast differentiation

21 January 2018

1 reference

https://api.crossref.org/works/10.1196%2FANNALS.1346.013

21 January 2018

Identifiers

DOI

10.1196/ANNALS.1346.013

1 reference

31 January 2017

1 reference